Sep 13, 2019
Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
Sep 05, 2019
Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
Sep 04, 2019
Innovative Drug-Delivery Systems Benefit Patients and Businesses
Sep 04, 2019
Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences
Aug 08, 2019
Achieve Reports Financial Results for Second Quarter 2019 and Provides Cytisinicline Clinical Development Update
Jul 23, 2019
Achieve Life Sciences Extends Collaboration with the National Institutes of Health to Advance the Development of Cytisinicline for Smoking Cessation
Jun 21, 2019
Achieve Life Sciences Announces Phase 2b ORCA-1 Trial Data Accepted for Oral Presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference
Jun 19, 2019
New National Study: Parents Miss Key Opportunities to Protect Kids from Risks of Substance Use as Teens Grow Older
Jun 03, 2019
Achieve Receives $4.2 Million from Exercise of Warrants
May 29, 2019
Fellowship Offers 700 Free Meetings in 32 Countries to Help You Stop Smoking or Vaping Nicotine
May 21, 2019
Nicorette and Dale Earnhardt Jr. Launch New Nicorette Coated Ice Mint Lozenges to Help Smokers Succeed on Their Quest to Quit
Apr 24, 2019
Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation
Apr 11, 2019
Statement from the Council of Chief Medical Officers of Health on the increasing rates of youth vaping in Canada
Apr 10, 2019
Veratad to Exhibit & Sponsor at Next Generation Nicotine Delivery 2019 USA
Apr 03, 2019
Achieve Life Sciences to Present at HC Wainwright Global Life Sciences Conference on April 8, 2019
Apr 02, 2019
NYSVA Finds It Tragic that Budget Taxes New Yorkers for Quitting Smoking
Apr 02, 2019
Achieve Life Sciences Announces Successful Completion of the Second and Final DSMC Review of Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation
Mar 14, 2019
Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
Mar 08, 2019
Global Nicotine Patch Market 2019-2023: Technological Innovations in Transdermal Drug Delivery Process
Feb 22, 2019
Achieve Announces Final Data from Cytisinicline Phase I/II Multi-Dose, Pharmacokinetic and Pharmacodynamics (PK/PD) Clinical Study to be Presented at Society for Research on Nicotine & Tobacco Annual Meeting